Russia Has Become A Leader In The Fight Against Coronavirus, Said The Head Of The Group Of Companies "Promomed"

Russia Has Become A Leader In The Fight Against Coronavirus, Said The Head Of The Group Of Companies "Promomed"
Russia Has Become A Leader In The Fight Against Coronavirus, Said The Head Of The Group Of Companies "Promomed"

Video: Russia Has Become A Leader In The Fight Against Coronavirus, Said The Head Of The Group Of Companies "Promomed"

Отличия серверных жестких дисков от десктопных
Video: The Continuing COVID-19 Pandemic: Current Issues and Glimpse Into the Future 2023, January
Anonim

NIZHNY NOVGOROD, 5 Feb - RIA Novosti. The efforts made by the Russian government to develop innovative drugs have provided Russia with absolute intellectual leadership in the world in terms of combating coronavirus infection, said Petr Bely, Chairman of the Board of Directors of Promomed Group.

The head of the Ministry of Industry and Trade of the Russian Federation Denis Manturov on Friday in Saransk opened a new ampoule production of drugs at the Biochemist pharmaceutical plant (part of the Promomed group). He called what was happening "an invaluable contribution of the Russian industry to the fight against covid" and noted that the Russian health care system is fully provided with drugs for the prevention and treatment of coronavirus.

"This is a big step in terms of medical support for Russian health care. The ampoule line with a capacity of up to 200 million ampoules per year is capable of solving all the acute problems that are now emerging, including with the supply of the country with low molecular weight heparins, which are so urgently needed for the treatment of coronavirus infection," - Bely said at the opening of a new line at the Biochemist plant.

He noted that now Biochemist produces almost the entire range of drugs recommended by the Ministry of Health for the treatment of coronavirus infection - modern antiviral drugs, antibacterial drugs and low molecular weight heparins.

“It is very important that in Russia we are together - both the government, which created special conditions for the development of innovative drugs, and the industry that was ready to accept this challenge - we fully coped with drug supply for all the main therapeutic lines of treatment for covid infection. absolute intellectual leadership in the world from the point of view of combating coronavirus infection and from the point of view of providing emergency measures for healthcare management, "said the chairman of the board of directors of Promomed Group.

He noted that as a result of this systematic work, at a time when Europe is entering another period of tightening quarantine measures, sanitary restrictions in Russia, on the contrary, are weakening.

"Thanks to the green corridor for innovative drugs that the Russian government has created, a vaccine appeared very quickly that shows extremely high therapeutic results and an extremely good safety profile. It will inevitably be in all countries of the world, including Europe," Bely said.

According to him, now it is important to retain and continue to use "the moment of leadership when the Russian pharmaceutical industry has shown its enormous innovative potential."

"It is very important that this impulse, which the Russian pharmaceutical industry has received, continues. So that these special conditions and focuses on the creation of innovative drugs in Russia are preserved, so that our pharmaceutical industry, including Biochemist, which is in the forefront of developers of innovative drugs, we, as an industry, continued to provide state-of-the-art drugs intended for the treatment of the most acute nosologies. Not only the fight against viral infections, but also in the field of cardiology, oncology, the treatment of diabetes and other diseases that cause maximum mortality, "summed up the chairman of the board of directors of the Group of Companies. Promomed ".

In 2020, the Biochemist plant developed and produced a drug for coronavirus infection - Areplivir (international non-proprietary name Favipiravir).According to the Ministry of Industry and Trade of the Russian Federation, since September the plant has increased the production of the drug by 10 times, up to 1 million units per month and plans to increase production to 2 million.

The latest data on the situation with COVID-19 in Russia and the world are presented on the stopcoronavirus.ru portal.

Popular by topic